Osteoarthritis: Which Treatments Work and Which Don't?
... worldwide who live in pain due to inconsistent treatment approaches and confusion about what therapies are most effective. The 25 evidence-based, ... basis and not as a long-term option. "As a consequence of the confusion over NSAIDs, some people may not be getting the care they need for pain," ...Do You Know You're Having a Stroke?
... or an unusual headache, which may be accompanied by a stiff neck, facial pain, pain between your eyes, vomiting or altered consciousness * confusion or problems with memory, spatial orientation or perception In such cases, a stroke gives no warning. But one possible sign of an impending ...St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins
... Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function. Just as eyeglasses improve ...U.S. Preventive Medicine: Employers Can Help Workers Avoid Heart Attacks
... offers these suggestions for employers: 1) Provide a proactive, thorough, employee-friendly portal to preventive health care that eliminates the confusion about what and when to do to be truly preventive. This should include health risk assessments (HRAs), lifestyle/behavior education opportunities, as ...U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks
... offers these suggestions for employers: 1) Provide a proactive, thorough, employee-friendly portal to preventive health care that eliminates the confusion about what and when to do to be truly preventive. This should include health risk assessments (HRAs), lifestyle/behavior education opportunities, as ...Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
... fatigue and hypertension. - Grade 2 AEs of lightheadedness and decreased sensation in soles and one serious adverse event of confusion in a patient with baseline history of dementia were also observed. -- No evidence of myelosuppression The maximum tolerated dose has not ...New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
... be monitored for worsening function and evaluated for risk/benefit of continuing MYCAMINE therapy. Adverse events with MYCAMINE included mental confusion and possible histamine-mediated symptoms (including rash, pruritus, facial swelling, and vasodilatation). About Astellas Pharma US, Inc. Astellas ...Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
... and neck cancer were infusion reaction (3%), cardiopulmonary arrest (2%), dermatologic toxicity (2.5%), mucositis (6%), radiation dermatitis (3%), confusion (2%), and diarrhea (2%). The most serious adverse reactions associated with ERBITUX in mCRC clinical trials (N=774) were infusion reaction ...Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
... and neck cancer were infusion reaction (3%), cardiopulmonary arrest (2%), dermatologic toxicity (2.5%), mucositis (6%), radiation dermatitis (3%), confusion (2%), and diarrhea (2%). The most serious adverse reactions associated with ERBITUX in mCRC clinical trials (N=774) were infusion reaction ...Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
... and neck cancer were infusion reaction (3%), cardiopulmonary arrest (2%), dermatologic toxicity (2.5%), mucositis (6%), radiation dermatitis (3%), confusion (2%), and diarrhea (2%). The most serious adverse reactions associated with ERBITUX in mCRC clinical trials (N=774) were infusion reaction ...Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
... and neck cancer were infusion reaction (3%), cardiopulmonary arrest (2%), dermatologic toxicity (2.5%), mucositis (6%), radiation dermatitis (3%), confusion (2%), and diarrhea (2%). The most serious adverse reactions associated with ERBITUX in mCRC clinical trials (N=774) were infusion reaction ...Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
... and neck cancer were infusion reaction (3%), cardiopulmonary arrest (2%), dermatologic toxicity (2.5%), mucositis (6%), radiation dermatitis (3%), confusion (2%), and diarrhea (2%). The most serious adverse reactions associated with ERBITUX in mCRC clinical trials (N=774) were infusion reaction ...